Solution Structure of Calmodulin Bound to the Target Peptide of Endothelial Nitric Oxide Synthase Phosphorylated at Thr495 by Piazza, Michael et al.
1 
Solution Structure of Calmodulin bound to the target 
peptide of Endothelial Nitric Oxide Synthase 
phosphorylated at Thr495 
Michael Piazza, Valentina Taiakina, Simon R. Guillemette, J. Guy Guillemette* and Thorsten 
Dieckmann* 
Department of Chemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada 
1 Funding Source Statement: This work was supported by the National Science and Engineering 
Research Council (NSERC) under grant no. 326911-2009 and 183521  
* To whom correspondence should be addressed: University of Waterloo, Dept. of Chemistry,
200 University Ave West, Waterloo, ON, N2L3G1, Canada. E-mail: tdieckma@uwaterloo.ca; 
Fax: +1-519-7460435; Tel: +1-519-8884567 
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Biochemistry, copyright © American Chemical Society 
after peer review and technical editing by publisher. To access the final edited and published work see http://dx.doi.org/10.1021/bi401466s
2 
 
Abbreviations: NOS, Nitric oxide synthase; iNOS, inducible NOS; eNOS,endothelial NOS; 
nNOS, neuronal NOS; cNOS,constitutive NOS; CaM, Calmodulin; NMR, Nuclear magnetic 
resonance; CaM-eNOS, CaM-eNOS binding domain peptide; CaM-eNOSpThr495, CaM-eNOS 
binding domain peptide with phosphorylated Thr495; PDB, Protein data bank; RMSD, root mean 
square deviation; NOE, Nuclear Overhauser Enhancement; NOESY, nuclear Overhauser effect 
spectroscopy; TOCSY, total correlation spectroscopy; HSQC, heteronuclear single-quantum 





ABSTRACT: Nitric oxide synthase (NOS) plays a major role in a number of key physiological 
and pathological processes and it is important to understand how this enzyme is regulated.  The 
small acidic calcium binding protein, calmodulin (CaM), is required to fully activate the enzyme. 
The exact mechanism of how CaM activates NOS is not fully understood at this time. Studies 
have shown CaM to act like a switch that causes a conformational change in NOS to allow for 
the electron transfer between the reductase and oxygenase domains through a process that is 
thought to be highly dynamic and at least in part controlled by several possible phosphorylation 
sites. We have determined the solution structure of CaM bound to a peptide that contains a 
phosphorylated threonine corresponding to Thr495 in full size eNOS in order to investigate the 
structural and functional effects that the phosphorylation of this residue may have on nitric oxide 
production. Our biophysical studies show that phosphorylation of Thr495 introduces electrostatic 
repulsions between the target sequence and CaM as well as a diminished propensity for the 
peptide to form an -helix. The calcium affinity of the CaM-target peptide complex is reduced 
due to phosphorylation and this leads to weaker binding under low physiological calcium 
concentrations.  This study provides an explanation for the reduced NO production by eNOS 




Nitric oxide synthase (NOS) enzymes (E.C. 1.14.13.39) catalyze the production of nitric oxide 
(•NO) that acts as a secondary inter- and intracellular messenger involved in many physiological 
processes.1 Three NOS isozymes are found in mammals: neuronal NOS (nNOS, NOS I), 
endothelial NOS (eNOS, NOS III), and inducible (iNOS, NOS II). The NOS enzymes are 
homodimeric with each monomer containing an N-terminal oxygenase domain, which contains 
binding sites for the catalytic heme, tetrahydrobiopterin (H4B), and the substrates L-arginine and 
molecular oxygen, and a C-terminal reductase domain, which contains binding sites for the 
cofactors FMN, FAD, and NADPH. A Calmodulin (CaM) binding domain connects the 
oxygenase and reductase domains and is required for efficient electron transfer from the 
reductase to the oxygenase domain for •NO production.1,2 CaM binds and activates the Ca2+- 
dependent constitutive NOS (cNOS) enzymes, eNOS and nNOS, at elevated cellular Ca2+ 
concentrations, whereas, iNOS is transcriptionally controlled in vivo by cytokines and binds to 
CaM in a Ca2+-independent manner. A large conformational change that CaM induces in the 
reductase domain of the NOS enzymes allows for the FMN domain to interact with the FAD to 
accept electrons and pass the electrons on to the heme during catalysis.3 Clearly, these 
conformational changes caused by CaM are important in stimulating efficient electron transfer 
within the NOS enzymes. 
   CaM is a ubiquitous cytosolic Ca2+-binding protein that is able to bind and regulate hundreds 
of different intracellular proteins.4 CaM consists of two globular domains joined by a flexible 
central linker region. Each domain contains two EF hand pairs that are each capable of binding 
one Ca2+ ion. The binding of Ca2+ to CaM causes a conformational change which exposes 
hydrophobic patches that allow it to associate with its intracellular target proteins. The flexibility 
of CaM’s central linker separating the N- and C-domains allows it to adapt its conformation to 
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optimally associate with its intracellular targets.5,6   Both the N- and C-lobes must be calcium 
replete to fully activate eNOS and nNOS enzymes.7,8  
eNOS activity is regulated by multiple mechanisms, including posttranslational modifications 
such as protein phosphorylation.9,10 The binding of CaM and the transfer of electrons from the 
reductase to the oxygenase domain of eNOS is dependent on protein phosphorylation and 
dephosphorylation.9 eNOS can be phosphorylated on serine, tyrosine and threonine residues and 
contains many potential phosphorylation sites that can play a role in regulating its activity.11–14 
Phosphorylation of Ser1177 in the reductase domain has been found to result in the activation of 
eNOS, whereas the phosphorylation of Thr495 within the CaM-binding domain has been found 
to reduce eNOS activity.15–17 Perturbations of eNOS phosphorylation have been reported in a 
number of diseases.18 Phosphorylation of Thr495 acts as a negative regulatory site and has been 
reported to interfere with the binding of CaM to the CaM-binding domain affecting activation of 
the enzyme.9,15 
There is considerable interest in understanding the structural and functional effects that the 
phosphorylation of Thr495 in eNOS has on the calcium dependent CaM binding and activation 
of the enzyme. In the present study the structural and functional effects that the phosphorylation 
of eNOS has on binding to CaM were investigated. Steady-state fluorescence and isothermal 
titration calorimetry (ITC) were used to monitor the binding of CaM to the wild type eNOS 
CaM-binding region peptide and the eNOS CaM-binding region peptide phosphorylated at 
Thr495 at various free Ca2+ concentrations. The structural effects of Thr495 phosphorylation on 
CaM binding to eNOS were investigated by the determination of the solution structure of CaM 
bound to the eNOS CaM-binding region peptide phosphorylated at Thr495. This investigation 
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provides a better understanding of the interaction of CaM with the phosphorylated or 
nonphosphorylated CaM-binding region of eNOS at Thr495. 
EXPERIMENTAL PROCEDURES 
CaM Protein Expression and Purification. Wild-type CaM protein was expressed and 
purified using phenyl sepharose chromatography, as previously described.7 Isolation of the CaM 
proteins (148 residues) was confirmed by ESI-MS and purity was judged to be > 95% by SDS-
PAGE. The human eNOS (TRKKTFKEVANAVKISASLMGT, 22 residues corresponding to 
residues 491-512 from the full length eNOS protein) peptide was synthesized and purchased 
from Sigma. The Thr495 phosphorylated human eNOS (TRKKpTFKEVANAVKISASLM, 20 
residues corresponding to residues 491-510 from the full length eNOS protein) peptide was 
synthesized and purchased from GenScript. The phosphorylation was confirmed by ESI-MS.  
Sample Preparation for NMR Investigation. CaM for NMR experiments were expressed in 
M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM 
CaCl2, 5 mg/mL Thiamine, 100 μg/mL kanamycin) containing 2 g/L 
13C-glucose and 1 g/L 
15NH4Cl. 
13C-15N CaM was purified as described above. The samples were prepared for NMR 
experiments via a buffer exchange into NMR solution (100 mM KCl, 10 mM CaCl2, 0.2 mM 
NaN3, 90% H2O/10% 
2H2O) at pH 6.0 using a YM10 centrifugal filter device (Millipore Corp., 
Billerica, USA). All NMR samples contained at least 1 mM CaM in a total volume of 500 μL. 
The samples were transferred into 5 mm NMR sample tubes and stored at 4oC until required for 
NMR experiments. NMR experiments on the complexes were conducted on CaM samples 
titrated with eNOSpT495 peptide to saturation in a 1:1 CaM:peptide ratio. Complex formation 
was monitored after each addition by acquisition of a 1H-15N heteronuclear single-quantum 
coherence (HSQC) spectrum.  
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NMR Spectroscopy and Data Analysis. NMR spectra were recorded at 25oC on Bruker 600 
and 700 MHz DRX spectrometers equipped with XYZ-gradients triple-resonance probes 
(Bruker, Billerica, MA, USA).  Spectra were analyzed using the program CARA (Computer 
Aided Resonance Assignment).19  
Specific assignments of the CaM backbone resonances were achieved using a combination of 
3D triple resonance experiments including HNCA, HN(CO)CA, CBCA(CO)NH, and HNCO.20,21 
Side-chain resonances were assigned using the TOCSY type experiments HC(C)H-TOCSY, 
(H)CCH-TOCSY and H(CCO)NH.22 Specific assignments of the eNOSpThr495 peptide were 
obtained from 15N-double-filtered NOESY experiments (Figure S.1).23 
Structure Calculation. The 1H, 13C and 15N resonance assignments were utilized to identify 
constraints for the structure calculations. Distance constraints for the solution structure of CaM-
eNOSpThr495 were obtained from 15N-NOESY-HSQC, 13C- NOESY-HSQC and 15N-double-
filtered NOESY spectra acquired on samples containing labeled CaM and unlabeled peptide.23–25 
In addition, dihedral angle restraints were derived from chemical shift analysis with TALOS+.26 
CNSsolve version 1.227 was used to perform the structure calculations using standard simulated 
annealing protocols. 
Delphi Calculation of the CaM Structures. Delphi electrostatic potentials of the structure 
was calculated using the DelPhiController interface of UCSF Chimera 1.5.3 (build 33475).28 The 
parseRes atomic radii file and atomic charge file were used as the input files in the calculation. 
The electrostatic potential surface was visualized in Chimera.  
Dansylation of CaM. Dansyl-CaM was prepared as previously described.29 CaM (1 mg/ml) 
was buffer exchanged into 10 mM NaHCO3, 1 mM EDTA, pH 10.0, at 4°C. 30 μl of 6 mM 
dansyl-chloride (1.5 mol/mol of CaM) in DMSO was added to 2 ml of CaM, with stirring. After 
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incubation for 12 hr at 4°C, the mixture was first exhaustively dialyzed against 500 volumes of 
150 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5, at 4°C, then exhaustively dialyzed 
against 500 volumes of water. Labeling yields were determined from absorbance spectra using 
the ε320 of 3,400 M
-1cm-1 and were compared to actual protein concentrations determined using 
the Bradford method with wild-type CaM used as the protein standard.30 ESI-MS was used to 
confirm successful dansyl-labeling of each CaM protein. The concentration of dansyl-CaM in all 
experiments was 2 μM.  
Steady State Fluorescence. Fluorescence emission spectra were obtained using a PTI 
QuantaMaster spectrofluorimeter (London,ON). Fluorescence measurements were made on 50 
μL samples consisting of dansyl-CaM (2 μM) alone or with eNOS or eNOSpThr495 peptide in 
30 mM MOPS, 100 mM KCl, 10 mM EGTA, pH 7.2 with an increasing concentration of free 
Ca2+. Free Ca2+ concentration was controlled using the suggested protocol from the calcium 
calibration buffer kit from Invitrogen. The excitation wavelength for all of the dansyl-CaMs was 
set at 340 nm and emission was monitored between 400 and 600nm. Slit widths were set at 2 nm 
for excitation and 1 nm for emission. Relative fluorescence was calculated by the following 
equation: relative fluorescence = (F - F0)/(Fmax - F0), where F is the measured intensity, Fmax is 
the maximum intensity, and F0 is the intensity without added Ca
2+. 
Isothermal Titration Calorimetry. All ITC recordings were performed on a Microcal 
ITC200 from Microcal (Northampton, MA) at 25°C, 1000 rpm stir speed, and reference power 
set to 5 µcal/s. In the experiments at saturating Ca2+ concentrations the buffer used was 30 mM 
MOPS, 100 mM KCl, pH 7.2 and 1 mM CaCl2 and was identical between cell and syringe. In the 
experiments at 225 nM free Ca2+ the calcium calibration buffer kit from Invitrogen was used and 
the buffer consisted of 15 mM MOPS, 50 mM KCl, pH 7.2 10 mM EGTA and 6.0 mM 
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CaEGTA and was identical between cell and syringe. Buffer into buffer, peptide into buffer and 
buffer into CaM controls showed no significant baseline decay or drift and relatively low, 
consistent heats of injection, indicating sufficiently matched cell and syringe buffer conditions.. 
39 µL of each peptide was titrated into 200 µL of CaM at varying concentrations (optimal 
starting conditions were determined empirically), typically from 100 µM peptide into 10 µM 
CaM to 500 µM peptide into 50 µM CaM, over the course of 20–30 injections at 2–3 min 
intervals. Data analysis was performed using Origin ITC200 Origin70 module with pre-loaded 
fitting equations for one- and two-sites models. The one-set-of-sites model was found to be 
applicable to all experiments. 
Circular Dichroism (Spectropolarimetry). CD was performed using a Jasco J-715 CD 
spectropolarimeter and analyzed using J-715 software(Jasco Inc., Easton, MD, USA) as 
previously described (Fernando et al., 2002) with some modifications. Samples were measured 
in a 1 mm quartz cuvette (Hellma, Concord, ON) and kept at 25°C using a Peltier type constant-
temperature cell holder (model PFD 3505, Jasco, Easton, MD). Samples consisted of 10 μM of 
synthetic eNOS or phosphorylated eNOS (peNOS) CaM-binding domain peptides.  Samples 
were in 10  mM Tris-HCl buffer (pH 7.5), 150 mM NaCl, containing 200 μM CaCl2 followed. 
Spectra were recorded over a 190-250 nm range with a 1.0 nm band width, 0.2 nm resolution, 
100 mdeg sensitivity at a 0.125 s response and a rate of 100 nm/min with a total of 25 
accumulations. Data is expressed as the mean residue ellipticity (θ) in degree cm2dmol-1. 
Accession Numbers. The coordinates and NMR parameters for the ‘Solution Structure of 
Calmodulin bound to the target peptide of Endothelial Nitrogen Oxide Synthase phosphorylated 
at Thr495' have been deposited in the PDB and BMRB and have been assigned RCSB ID code 




RESULTS AND DISCUSSION 
CD and NMR Spectroscopy. NMR spectroscopy was used to assess changes to the CaM-
eNOS complex due to the phosphorylation of Thr495. Figure 1a shows the overlay of the 15N-
HSQC spectra of CaM-eNOS with that of CaM-eNOSpThr495. Cross peaks for the majority of 
amides in the CaM-eNOSpThr495 complex overlap with those of CaM-eNOS complex. 
However, amides in the C-domain, specifically the amides of residues in EF hand IV, do not 
overlap with those of CaM-eNOS due to differences in chemical shifts. Also not seen in Figure 
1a is the chemical shift difference of E7, which is located in the heavily overlapped central 
portion of the spectra. This data suggests that the structures of the CaM-eNOS complex and the 
CaM-eNOSpThr495 complex are quite similar. This provides further evidence that this 
phosphorylation affects residues E7 and E127, which are in close proximity to the 
phosphorylated Thr495 in the structure. This has been previously postulated by Aoyagi et al. 
when they suggested that the addition of a negatively charged phosphate group would cause 
electrostatic repulsion between E7 and E127.31 
The effect of phosphorylation on the secondary structure of the peptide was investigated using 
trifluoroethanol (TFE) monitored by circular dichroism spectroscopy. The TFE is used to mimic 
hydrophobic environments and is known to induce α-helical conformation in peptides that have a 
propensity to form this secondary structure. Both eNOS peptides showed no apparent structure in 
the buffer solution with 0% TFE. A comparison of the tendency of each peptide to form an α-
helix was then performed by recording spectra after the addition of increasing concentrations of 
TFE. The formation of an α-helix is generally accompanied by the appearance of negative 
ellipticity at 208 and 222 nm. Both peptides showed increased amounts of secondary structure as 
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more TFE was added. In both cases, there was an increase in apparent α-helical structure with 
increasing TFE concentration. With increasing concentrations of TFE, the negative ellipticity at 
222 nm of both peptides plateau at TFE concentrations above 30% (see Figure 1b). While this 
result indicates that the increase in helical structure does not appreciably change above 30% 
TFE, the phosphorylated peptide did not show as large an α-helical content as the 
nonphosphorylated peptide (Figure 1b).  The structural effects of the phosphorylation leading to 
the diminished helical structure of the peptide can be due to the charged and bulky nature of the 
phosphate, destabilization of electrostatics that can result in nonproductive interaction with 
neighboring residues or the high desolvation penalty of the side chain.32 Specifically, it has been 
previously proposed that phosphorylation at Thr495 OG1 would disrupt its hydrogen bond with 
the Glu498 backbone amide, possibly affecting the α-helical secondary structure of the peptide.31 
In addition, the Thr495 is next to one of the anchoring residues in the classical ‘1-5-8-14’ CaM 
binding sequence motif.  A negatively charged phosphorylated Thr495 next to the first residue of 
the motif will likely disrupt the helical structure of the region.  
While the propensity of the phosphorylated eNOS CaM binding domain to form an -helix 
appears to be diminished, the final structure of the peptide bound to CaM is very similar to that 
of the nonphosphorylated form of the peptide. The diminished -helical propensity could 
account for the reduced activity of the enzymes associated with the phosphorylated form.   
Structure of CaM-eNOSpThr495 CaM Binding Peptide Complex. The three dimensional 
solution structure of CaM bound to the human eNOS CaM binding domain peptide 
phosphorylated at Thr495 (CaM-eNOSpThr495) was determined using multi-dimensional 
heteronuclear NMR spectroscopy. The structure of the complex is based on a large number of 
experimental constraints and is well defined. Structure and input data statistics are summarized 
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in Table 1. The family of 20 final structures is shown in Figure 2a. The average structure 
showing the location of the phosphorylation of Thr495 of the eNOS peptide, which is found near 
the N-terminal end of the peptide is shown in Figure 2b. Residues 1-4 (corresponding to 491-494 
of eNOS) at the N-terminus of the eNOSpThr495 CaM binding region peptide were not included 
in the structure calculation because they could not be unambiguously assigned. This could be due 
to the addition of the phosphate group which has been theorized to destabilize the helical 
propensity of the peptide.31 Based on the comparison of the 15N-double filtered NOESY 
experiments for CaM with eNOS peptide and CaM with eNOSpThr495 peptide there was little 
change in the chemical shifts observed for pThr495 and Thr495.  
Comparison of the CaM-eNOS vs CaM-eNOSpThr495 Complexes. When the solution 
structure of CaM-eNOS is superimposed onto that of the CaM-eNOSpThr495 structure, the two 
structures are shown to be quite similar, however, a few local differences are seen (Figure 3). 
When aligned with respect to the backbone atoms of the peptide, a difference is shown in the 
orientation of helix A of CaM between the two structures, with helix A of CaM-eNOSpThr495 
pushed away from the N-terminus of the peptide (where the phosphorylated Thr495 is located). 
EF hand IV (colored blue) is also shifted farther away from the peptide in the CaM-
eNOSpThr495 structure. The rest of the CaM-eNOSpThr495 structure superimposes quite well 
on the CaM-eNOS structure. This, along with the 15N-HSQC spectra overlay, confirms that the 
phosphorylation of Thr495 doesn’t have an effect on the structure of CaM away from the site of 
the phosphorylation. 
Electrostatic Effects of the Phosphorylation of Thr495. The addition of the phosphate group 
to Thr495 of the eNOS peptide shows structural effects on EF hands I and IV. This is first 
illustrated by the 15N-HSQC spectra overlay of the CaM-eNOS and CaM-eNOSpThr495 
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complexes (Figure 1a) and is clearly shown by the structure overlay of the two structures (Figure 
3). The analysis of the CaM-eNOSpThr495 structure with DelPhi illustrates that this 
modification to the peptide creates a more negative potential on the N-terminal region of the 
peptide, which is located in a negatively charged region of CaM (Figure 4b, d). This negative 
charge is not present in the CaM-eNOS complex (figure 4c) and thus would not cause any 
electrostatic repulsion. This phosphate group is in close proximity to E7, which is found in helix 
A of EF hand I, and E127, found in helix G of EF hand IV. The electrostatic repulsion between 
the phosphate group and helix A of EF hand I gives an explanation as to why helix A is pushed 
further from the peptide in the CaM-eNOSpThr495 complex, as shown in Figure 3. This also 
explains why helix G and EF hand IV are shifted further away from the eNOSpThr495 peptide. 
This electrostatic repulsion could be affecting CaM’s ability to coordinate Ca2+ by interfering 
with the EF hands I and IV, which would help explain why CaM has diminished ability to bind 
eNOS phosphorylated at Thr495 at physiological Ca2+ levels. 
Fluorescence Spectroscopy Suggests Increased Ca2+ Sensitivity of CaM with the eNOS 
Peptide. Binding of the eNOS and eNOSpThr495 peptides with CaM was further studied using 
dansylated CaM (dansyl-CaM). Dansyl-CaM is a useful tool to detect conformational changes in 
CaM as a result of interactions with Ca2+, peptides or other proteins because the intensity of the 
fluorescence spectrum is enhanced and shifted when the dansyl moiety becomes embedded in a 
hydrophobic environment.29,33 Without Ca2+ present there was no blue shift or enhancement of 
dansyl fluorescence spectrum observed when eNOS peptide or eNOSpThr495 peptide were 
added. In the presence of Ca2+, this shift and enhancement of the fluorescence spectrum was 
observed. To analyze the Ca2+ dependency of the two complexes we performed Ca2+ titration 
fluorescence experiments in triplicate (Figure 5). Without peptides, dansyl-CaM exhibited 
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fluorescence changes in a Ca2+ concentration range of 0.35-2.8 µM. The fluorescence changes of 
the dansyl-CaM-eNOS complex occurred in a much lower Ca2+ concentration range, which may 
correspond to a physiological Ca2+ concentration. The dansyl-CaM-eNOSpThr495 complex 
showed no difference in Ca2+ dependency when compared to CaM alone. These Ca2+ titration 
experiments provide information about the conformational transitions of CaM with the peptides 
and Ca2+. The result of the CaM-eNOS complex binding with Ca2+ at lower Ca2+ concentrations 
than CaM alone indicate that the Ca2+ affinity of CaM is enhanced with peptide binding to CaM. 
This is not seen in interaction of CaM with eNOSpThr495 peptide. This increased Ca2+ 
sensitivity of CaM have also been seen with other peptides interacting with CaM.34 This suggests 
that binding of eNOS peptide to CaM increases the Ca2+ sensitivity of CaM in the physiological 
Ca2+ range, whereas eNOSpThr495 does not. 
    Isothermal titration calorimetry. Isothermal titration calorimetry (ITC) was used to examine 
the thermodynamic profiles associated with the binding CaM to the two target peptides. Since 
the values obtained for binding constants show slight variations when performed using different 
methods and conditions,35,36  all of our experiments were performed by ITC using exactly the 
same conditions. Representative titrations for each are shown in figure 6. In the presence of 
excess calcium (1mM) wild type eNOS peptide binds to CaM by an exothermic interaction. As 
previously reported for the binding of the nNOS peptide,37 eNOS binding proceeds with a 
negative enthalpy (ΔH) and a positive entropy (ΔS) and modest affinity (Kd = 0.7µM). This 
indicates that the interaction is driven by favorable enthalpy and entropy. In contrast, the binding 
of the eNOSpThr495 peptide under the same conditions is weakly endothermic, with a 
comparable affinity to that of wild type (Kd = 0.3µM). A similar endothermic interaction has 
been reported for apoCaM titrated with mutant peptides corresponding to the CaM binding 
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domain of  iNOS, an isoform that is known to bind to CaM in the absence of calcium.38 The 
eNOSpThr495 binding interaction proceeds with positive ΔH and ΔS. The interaction is 
therefore driven by the increase in entropy. Both peptides showed a 1:1 stoichiometry with CaM 
as expected.  
Since our fluorescence studies showed an apparent difference in binding at low calcium 
concentrations, we attempted to thermodynamically characterize the interactions under these 
conditions. Intriguingly, at low [Ca2+]free, the binding of wild type eNOS peptide to CaM 
becomes highly endothermic, the entropy gain increases over fourfold, and its affinity for CaM 
increases slightly (Kd = 0.2µM). A similar result showing a switch from an exothermic to an 
endothermic interaction has been reported for the binding of the nNOS CaM target domain to 
CaM by simply changing the experimental conditions going from a higher to a lower 
temperature.37 The ΔH under low 225nM calcium conditions is now positive and unfavorable for 
binding. The change in enthalpy is compensated by a much larger positive ΔS than that observed 
for the wild type peptide binding in excess calcium. In contrast, the binding of eNOSpThr495 to 
CaM in these low [Ca2+]free conditions becomes negligible (Figure 6). This is consistent with our 
fluorescent experiments showing no apparent binding under these conditions. In essence, these 
results indicate that non-phosphorylated eNOS is more sensitive to ambient cellular Ca2+, and 
phosphorylation serves as an attenuator of Ca2+-CaM regulation of eNOS. 
We set out to understand how phosphorylation of a single residue in the CaM target domain 
results in diminished NOS enzyme activity. Previous studies had shown that an eNOS enzyme 
carrying a phosphomimetic mutation T495D binds very weakly to CaM. In contrast, the control 
mutant T495A showed strong binding to CaM.15 Enzyme studies also showed that only 
phosphorylation of T495 or the mutation T495D resulted in the loss of eNOS enzyme activity. It 
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had been postulated that phosphorylation of T495 reduces output by hindering the association of 
CaM with its binding site.31 Until the present study, there had not been a structural study using a 
phosphorylated T495 residue. Our solution structure shows that in the presence of excess 
calcium, phosphorylation does not prevent the binding of CaM to the phosphorylated peptide. 
While the exact mechanism of how phosphorylation of Thr495 in eNOS adversely affects the 
activation of the enzyme is still unknown, a careful look at the complex does provide some idea 
of the reported cause for the reduced enzyme activity. A comparison of the two structures in 
figures 1 and 2 show that the most significant changes in the pThr495 solution structure involved 
two CaM amino acids E7 and E127. In addition both E11 and M124 are found to be in close 
proximity to the pThr495 phosphate group. The previously reported crystal structure of CaM 
bound to the human eNOS peptide shows that the side chains of these amino acids are in contact 
with a number of amino acids in the eNOS peptide.31 Both E7 and E11 are part of helix A of the 
EF hand 1 in CaM. The E7 side chain is in contact with eNOS residues K497 and E498 and has 
ionic interactions with R492. The E11 side chain is in contact with eNOS residues E498, A502 
and I505 and has a hydrogen bond with N501. Our results shown in Figure 3 indicate that helix 
A is pushed away from the peptide likely due to electrostatic repulsion.  
The M124 and E127 residues are both in helix G of EF hand 4 in CaM.  The side chain of 
M124 is in contact with eNOS residues T495, F496 and V499. Residue E127 of CaM has contact 
with T495 and K497. In addition E127 has ionic interactions with K493 and the backbone of 
T496. Electrostatic repulsion could again account for the displacement of helix G of EF hand 4 
away from the peptide (Figure 3). Looking closely at the Delphi image with the phosphate 
present, the phosphorylation of Thr495 adds a negative charge that is close to helix G (Figure 4).  
The displacement of helix A and G may not be significant under conditions with 1 mM calcium, 
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but under physiological low calcium concentration conditions, a more significant displacement 
of these helices may have a detrimental effect on enzyme binding and activation. This comes 
from our dansyl-CaM experiments showing that the pThr495 peptide required significantly 
higher concentrations of calcium to bind to CaM. Our calorimetric study also showed a lack of 
binding of CaM to the phosphorylated peptide in the presence of 225nM free calcium. We used 
TFE to induce α-helical formation and used spectropolarimetry to monitor the changes in the 
secondary structure of the two eNOS peptides. The secondary structure of both peptides plateaus 
in 30% TFE but phosphorylation appears to result in a reduction in the degree of α-helical 
structure in the peptide. In the presence of high concentrations of calcium, the solution structure 
shows that both peptides form an α-helical structure when bound to CaM. 
In summary, the interactions of CaM with the peptides based on the eNOS CaM binding 
domain or the eNOS CAM binding domain phosphorylated at Thr495 are very similar at 
saturating Ca2+ concentrations. This is confirmed by our NMR spectroscopy (see Figure S2,), 
fluorescence and ITC results. At the lower Ca2+ concentration of 225nM, near physiological Ca2+ 
levels, no significant binding of CaM to eNOSpThr495 is observed by either method, whereas 
CaM is binding to nonphosphoryated eNOS. When Thr495 is phosphorylated, our results 
indicate there is a diminished propensity for the formation of an α-helix by the peptide in 
combination with electrostatic repulsion that may account for the diminished CaM-dependent 
activation of the eNOS enzyme under low physiological calcium concentrations. 
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SUPPORTING INFORMATION AVAILABLE. 15N-double filtered NOESY spectrum of 
CaM with the eNOSpThr495 peptide bound, Overlay of 1H-15N HSQC spectra of CaM and 
CaM-eNOS peptide complex at 225nM free Ca2+, Overlay of 1H-15N HSQC spectra of CaM and 
CaM-eNOSpThr495 peptide complex at 225nM free Ca2+. This material is available free of 
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Table 1. Statistics for the CaM-eNOSpThr495 Peptide Structural Ensemble 
 CaM-eNOSphos Complex 
NMR-derived distance and dihedral angle restraints 
NOE constraints Calmodulin eNOSphos peptide CaM-eNOSphos complex 
Total 1513 119 62 
Dihedral angles from 
TALOS+ 
288 N/A N/A 
Total number of 
restraints 
1982 
Structure statistics for the 20 lowest energy structures 
Mean deviation from 
ideal covalent geometry 
 
Bond lengths (Ǻ)  0.010 
Bond angles (deg.) 1.3 
Average pairwise 
RMSD (Ǻ) for all heavy 
atoms of the 20 lowest 
energy structures 
All Residues Ordered Residuesa Selected Residuesb 
Backbone Atoms  1.3 0.9 0.9 




Residues in most 
favored region  
86.0 
Residues in additional 









a Ordered residue ranges: 6A-8A,10A-36A,39A-77A,79A-148A,495B-508B 




Table 2. Thermodynamics of CaM-Peptide Interactions Measured by ITC   
 N (sites) Kd (μM) ΔH (kcal/mol) ΔS (cal/mol/K) 
CaM + eNOS 0.225 
μM free Ca2+ 
1.00 ± 0.01 0.2 ± 0.03 9.39 ± 0.13 62.0 
CaM + eNOS  1mM 
free Ca2+ 
1.02 ± 0.02 0.7 ± 0.2 -4.48 ± 0.16 13.3 
CaM + eNOSpThr495 
0.225 μM free Ca2+ 
0.0096 ± 0.86* >50 41.07 ± 369.9* 140* 
CaM + eNOSpThr495  
1 mM free Ca2+ 
1.11 ± 0.01 0.3 ± 0.08 1.74 ± 0.03 35.5 
*These results cannot be fit reliably by the ITC software and are indicative of poor or no binding 




FIGURE CAPTIONS  
FIGURE 1. (a) Overlay of 1H-15N HSQC spectra of CaM-eNOS peptide complex (green) and 
CaM-eNOSpThr495 peptide complex (red). (b) UV-CD spectra comparison between wild type 
eNOS and eNOSpThr495 CaM binding peptides in buffers with varying TFE concentration.  The 
ellipticiy at 222 nm is shown as a function of the concentration of TFE. 
FIGURE 2.  Solution structure of CaM bound to eNOSpThr495 CaM binding domain peptide.  
(a) Superposition of the ensemble of the 20 lowest energy structures of CaM bound to the 
eNOSpThr495 peptide. Backbone atom traces of CaM are shown in dark blue and the 
eNOSpThr495eNOS peptide are shown in light blue. (b) Cartoon ribbon view of the average 
solution structure of CaM-eNOSpThr495 complex. (c) Cartoon ribbon view showing residues in 
close proximity to the phosphorylated Thr495 of the eNOS peptide. Ca2+ ions are shown as green 
dots and are modeled in their known locations. Residues 1-40 of CaM (EF Hand I) are colored 
red, 41-79 (EF Hand II) are purple, 80-114 (EF Hand III) are green, and 115-148 (EF Hand IV) 
are blue. The peptide is colored in a lighter blue and the N and C terminus are labeled N’ and C’, 
respectively. The phosphorylated Threonine is shown as stick model. 
FIGURE 3. Superpositions of the CaM-eNOS peptide solution structure (dark colors) and the 
CaM-eNOSpThr495 peptide solution structure (light colors). Comparison of solution structures 
of CaM-eNOSpThr495 peptide (dark colors) with CaM-eNOS peptide by superimposing the two 
structures and viewing it along the bound peptide from its N-terminus (N’) to its C-terminus (C’) 
on the left (front view), and rotated 90° around the horizontal axis with the N-terminus of the 
bound peptide on the top on the right (bottom view). The two structures are aligned by 
superimposing backbone atoms of the bound peptides. The color scheme is the same as figure 1. 
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FIGURE 4. The Delphi-calculated electrostatic potential maps are projected on the surface of the 
CaM-eNOS peptide complex (a,c) and the CaM-eNOSpThr495 peptide complex (b,d). Thr495 
and pThr495 are displayed on the peptide by an * and . The Delphi-calculated electrostatic 
potential maps are colored with a chimera color key ranging from (-15) red to (0) blue.  
FIGURE 5. Ca2+ dependency of dansyl-CaM fluorescence with or without eNOS and 
eNOSpThr495 peptides. Normalized fluorescence is shown for CaM, CM-eNOS complex, and 
CaM-eNOSpThr495 under assay conditions described under Materials and Methods.  
FIGURE 6. Isothermal Calorimetry (ITC) analysis indicates binding of the eNOS peptide and no 
binding of eNOSpThr495 peptide to CaM at physiological Ca2+ levels. Representative raw 
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